AKBA EBITDA Growth
Akebia Therapeutics Inc · EBITDA Growth
AKBA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-266.61%period ending
AKBA TTM EBITDA YoY % (-250.94% → -266.61%)
Year-over-year change
High-resolution chart · PNG
AKBA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -266.6122% | |
| -220.1251% | |
| 251.7885% | |
| 473.2181% | |
| 172.7205% | |
| 75.7698% | |
| -73.1881% | |
| 247.8643% | |
| 110.204% | |
| -39.1343% | |
| 69.9924% | |
| 97.2978% | |
| 59.2056% | |
| 102.14% | |
| 87.2931% | |
| 57.14% | |
| 56.4003% | |
| 34.0639% | |
| 30.423% | |
| 34.3099% | |
| 31.4391% | |
| -51.365% | |
| -37.6423% | |
| -32.8778% | |
| -41.4867% | |
| 2.5689% | |
| -30.0483% | |
| -226.8954% | |
| -217.5518% | |
| -266.5294% | |
| -119.4704% | |
| 41.141% | |
| 48.7502% | |
| 62.0859% | |
| 41.7614% | |
| -8.8779% | |
| -38.3207% | |
| -102.4545% | |
| -122.0657% | |
| -129.8141% | |
| -146.0033% | |
| -99.5308% | |
| -64.9756% | |
| -73.2575% | |
| -71.2769% | |
| -134.7807% | |
| -297.8928% | |
| -250.9435% |